about
Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissuesRetinoic acid promotes the generation of pancreatic endocrine progenitor cells and their further differentiation into beta-cellsGenomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.Pisrt1, a gene implicated in XX sex reversal, is expressed in gonads of both sexes during mouse development.Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma.Global expression profiling of murine MEN1-associated tumors reveals a regulatory role for menin in transcription, cell cycle and chromatin remodelling.Alterations in gene expression in MEN1-associated insulinoma development.BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy.Effect of Obstructive Sleep Apnea Treatment on Renal Function in Patients with Cardiovascular Disease.The coactivator-associated arginine methyltransferase is necessary for muscle differentiation: CARM1 coactivates myocyte enhancer factor-2.Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice.Etiology of ovarian failure in blepharophimosis ptosis epicanthus inversus syndrome: FOXL2 is a conserved, early-acting gene in vertebrate ovarian development.Sex Determination: The Fishy Tale of Dmrt1The Effects of Long-term CPAP on Weight Change in Patients With Comorbid OSA and Cardiovascular DiseaseSleep duration and risk of cardiovascular events: The SAVE studyContinuous Positive Airway Pressure Treatment, Glycemia, and Diabetes Risk in Obstructive Sleep Apnea and Comorbid Cardiovascular DiseaseEffect of Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep Apnea with Cardiovascular DiseaseHigh Risk Characteristics for Recurrent Cardiovascular Events among Patients with Obstructive Sleep Apnoea in the SAVE Study
P50
Q28589655-AE225187-5831-479E-A25A-339909FDD316Q33356050-F49C5D6F-AF38-467B-A8F1-062D9B98CF98Q34445264-D5173B7E-A4DC-4A56-ACE5-9D8A7F4E6EA8Q34447783-2C06DE3E-B7D2-4788-A5D0-A32DAEC8765CQ36725997-106AFF28-85F9-4188-B49C-6FAD93D03A8BQ38302417-03703D88-78EA-4815-8242-D0F155FD912BQ38343480-EBCFD0D3-CD87-4937-A443-96210E5A2B29Q39152540-2DB097E5-7550-4EF8-AA50-46DF3364FEC0Q40108897-1ED695F8-F2AE-4F65-9060-99CEBF137837Q40768023-0E50CC4B-31AD-4C19-A2FA-72A3D0B355D4Q48336305-3DC516D7-2495-4FEA-BCDC-12F5E629E533Q52104040-01D581E7-D284-47B8-9781-623D0F6CBCD8Q60411794-65DE3D7D-174F-457A-813A-614D727B2C7BQ61466172-109DC6B5-30CA-4A35-A252-28E6EA6DFE22Q89513485-7D23F8AD-7F5A-43F4-B11A-41C079C6E14FQ91932772-24E917E0-929B-4FDC-8E54-B425F481466DQ92228715-67734E8F-9336-4717-8D6E-87E9F421E95FQ92712338-769CD301-44D0-48A5-86C2-BBBE9FA8364E
P50
description
Forscher
@de
chercheur
@fr
hulumtuese
@sq
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Kelly A Loffler
@ast
Kelly A Loffler
@en
Kelly A Loffler
@es
Kelly A Loffler
@nl
type
label
Kelly A Loffler
@ast
Kelly A Loffler
@en
Kelly A Loffler
@es
Kelly A Loffler
@nl
prefLabel
Kelly A Loffler
@ast
Kelly A Loffler
@en
Kelly A Loffler
@es
Kelly A Loffler
@nl
P108
P106
P1153
7004621765
P21
P31
P496
0000-0003-3302-5995